首页> 外文期刊>Neurogenetics >Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents.
【24h】

Inter-laboratory comparison of DNA preservation in archival paraffin-embedded human brain tissue from participating centres on four continents.

机译:来自四大洲参与中心的存档石蜡包埋的人脑组织中DNA保存的实验室间比较。

获取原文
获取原文并翻译 | 示例
           

摘要

DNA extracted from formalin-fixed and paraffin-embedded brain tissue is known to contain as yet ill-characterized inhibitors of the PCR process. As part of a project that aims to clarify the role of mitochondrial DNA sequence variation in human neurodegenerative diseases using DNA from various ethnic backgrounds, we have investigated factors that influence the preservation of archival DNA and its suitability for PCR. In this study, neuropathological tissue samples were analysed that had been routinely processed in 18 international centres on four continents. Following DNA extraction, PCR amplification of mitochondrial and nuclear DNA sequences was performed with and without additional purification of the template DNA. In addition, the DNA used for PCR was analysed by HPLC. Phosphate-buffered formalin proved to be a superior fixative compared with unbuffered aldehyde: DNA extraction resulted in greater yields, the molecular weight of the isolated DNA was higher and PCR was more successful. PCR inhibitors were identified as (1) high concentrations of small (<300 bp) DNA fragments that competitively compete with template DNA and (2) contaminants of the DNA template solution including denatured protein that cannot be completely removed by phenolic extraction. HPLC analysis did not reveal significant qualitative differences between DNA isolated from fresh-frozen tissue samples and DNA recovered from formalin-fixed, paraffin-embedded brain tissue. The fact that DNA could be amplified from the majority of tissue specimens in this study suggests that rare diseases and diseases where ethnic background plays an important role can be sampled for genetic polymorphism analysis on a global scale using archival neuropathological collections.
机译:从福尔马林固定的和石蜡包埋的脑组织中提取的DNA已知含有PCR过程中尚未充分表征的抑制剂。作为旨在阐明线粒体DNA序列变异在人类神经退行性疾病中的作用的项目的一部分,该研究使用了来自不同种族背景的DNA,我们研究了影响档案DNA的保存及其对PCR的适用性的因素。在这项研究中,分析了神经病理组织样本,这些样本在四大洲的18个国际中心进行了常规处理。 DNA提取后,在有或没有额外纯化模板DNA的情况下进行线粒体和核DNA序列的PCR扩增。另外,通过HPLC分析用于PCR的DNA。与未缓冲的醛相比,磷酸缓冲的福尔马林被证明是一种优异的固定剂:DNA提取可产生更高的收率,分离出的DNA的分子量更高,PCR更为成功。 PCR抑制剂被确定为(1)与模板DNA竞争竞争的高浓度小(<300 bp)DNA片段,以及(2)DNA模板溶液中的污染物,包括无法通过酚醛萃取完全去除的变性蛋白质。 HPLC分析未显示从新鲜冷冻组织样品中分离的DNA与从福尔马林固定,石蜡包埋的脑组织中回收的DNA之间存在明显的质量差异。在这项研究中,可以从大多数组织样本中扩增DNA的事实表明,可以使用档案神经病理学样本对罕见疾病和种族背景起重要作用的疾病进行采样,以进行全球范围的遗传多态性分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号